PT Kalbe Farma Tbk. (IDX: KLBF)

PT Kalbe Farma Tbk. Income Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	31,598,456	30,449,134	28,933,503	26,261,195	23,112,655	22,633,476
Revenue Growth (YoY)	4.50%	5.24%	10.18%	13.62%	2.12%	7.40%
Cost of Revenue	19,705,142	18,897,645	17,414,902	15,156,133	13,038,095	12,549,611
Gross Profit	11,893,314	11,551,489	11,518,601	11,105,061	10,074,560	10,083,866
Selling, General & Admin	7,607,184	7,591,031	7,008,307	6,800,994	6,238,255	6,486,989
Research & Development	331,580	322,297	286,805	285,159	281,059	286,655
Other Operating Expenses	-23,015	-11,322	-24,730	-11,954	-31,247	-26,331
Operating Expenses	7,915,748	7,902,006	7,270,382	7,074,199	6,488,067	6,747,312
Operating Income	3,977,566	3,649,483	4,248,219	4,030,862	3,586,493	3,336,553
Interest Expense	-70,859	-82,958	-41,226	-45,486	-75,837	-31,055
Interest & Investment Income	123,153	88,218	81,827	110,792	151,559	137,938
Earnings From Equity Investments	19,537	26,972	36,498	80,070	21,698	5,135
Currency Exchange Gain (Loss)	27,852	-55,928	155,833	-20,022	29,621	-21,003
Other Non Operating Income (Expenses)	-11,942	-12,146	-13,833	-11,898	-13,744	-9,365
EBT Excluding Unusual Items	4,065,308	3,613,641	4,467,318	4,144,318	3,699,791	3,418,203
Impairment of Goodwill	-	-	-	-	-98,054	-
Gain (Loss) on Sale of Investments	-	15,850	12,105	20,305	42,649	-
Gain (Loss) on Sale of Assets	1,093	1,093	3,038	7,782	19,395	16,480
Pretax Income	4,066,401	3,630,584	4,482,461	4,172,405	3,663,782	3,434,683
Income Tax Expense	973,851	852,179	1,032,378	940,397	864,159	897,081
Earnings From Continuing Operations	3,092,550	2,778,405	3,450,083	3,232,008	2,799,623	2,537,602
Minority Interest in Earnings	-49,703	-11,657	-67,874	-48,386	-66,363	-30,837
Net Income	3,042,847	2,766,748	3,382,210	3,183,621	2,733,260	2,506,765
Net Income to Common	3,042,847	2,766,748	3,382,210	3,183,621	2,733,260	2,506,765
Net Income Growth	-7.07%	-18.20%	6.24%	16.48%	9.04%	2.02%
Shares Outstanding (Basic)	46,181	46,256	46,516	46,873	46,873	46,875
Shares Outstanding (Diluted)	46,181	46,256	46,516	46,873	46,873	46,875
Shares Change (YoY)	-0.60%	-0.56%	-0.76%	-0.00%	-0.00%	-
EPS (Basic)	65.89	59.81	72.71	67.92	58.31	53.48
EPS (Diluted)	65.89	59.81	72.71	67.92	58.31	53.48
EPS Growth	-6.50%	-17.74%	7.05%	16.48%	9.04%	2.02%
Free Cash Flow	3,789,173	2,025,924	566,431	2,322,036	3,294,552	769,646
Free Cash Flow Per Share	82.05	43.80	12.18	49.54	70.29	16.42
Dividend Per Share	31.000	31.000	38.000	35.000	28.000	26.000
Dividend Growth	-18.42%	-18.42%	8.57%	25.00%	7.69%	0%
Gross Margin	37.64%	37.94%	39.81%	42.29%	43.59%	44.55%
Operating Margin	12.59%	11.99%	14.68%	15.35%	15.52%	14.74%
Profit Margin	9.63%	9.09%	11.69%	12.12%	11.83%	11.08%
Free Cash Flow Margin	11.99%	6.65%	1.96%	8.84%	14.25%	3.40%
EBITDA	4,662,542	4,314,625	4,907,579	4,649,287	4,146,252	3,807,141
EBITDA Margin	14.76%	14.17%	16.96%	17.70%	17.94%	16.82%
D&A For EBITDA	684,977	665,142	659,360	618,424	559,759	470,587
EBIT	3,977,566	3,649,483	4,248,219	4,030,862	3,586,493	3,336,553
EBIT Margin	12.59%	11.99%	14.68%	15.35%	15.52%	14.74%
Effective Tax Rate	23.95%	23.47%	23.03%	22.54%	23.59%	26.12%
Advertising Expenses	-	2,110,219	2,062,426	1,999,089	1,635,342	1,723,583

Source: S&P Capital IQ. Standard template. Financial Sources.